{"DataElement":{"publicId":"3624742","version":"1","preferredName":"Accelerated Phase Finding Present Abnormal Finding Type","preferredDefinition":"A description of the accelerated phase findings that were present.","longName":"3624738v1.0:2940570v1.0","context":"NHLBI","contextVersion":"1","DataElementConcept":{"publicId":"3624738","version":"1","preferredName":"Accelerated Phase of Disease Finding Present","preferredDefinition":"The phase of a disease characterized by laboratory and clinical findings that indicate rapid progression._Clinical, laboratory or molecular evidence, or absence of evidence of disease._Being or existing in a specified place or at the specified time.","longName":"4285041v1.0:2233878v1.0","context":"NHLBI","contextVersion":"1","ObjectClass":{"publicId":"4285041","version":"1","preferredName":"Accelerated Phase of Disease Finding","preferredDefinition":"The phase of a disease characterized by laboratory and clinical findings that indicate rapid progression.:Clinical, laboratory or molecular evidence, or absence of evidence of disease.","longName":"C36155:C3367","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Accelerated Phase of Disease","conceptCode":"C36155","definition":"The phase of a disease characterized by laboratory and clinical findings that indicate rapid progression.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Finding","conceptCode":"C3367","definition":"Clinical, laboratory or molecular evidence, or absence of evidence of disease.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F84480CD-6711-7BD7-E040-BB89AD436CEA","latestVersionIndicator":"Yes","beginDate":"2014-04-30","endDate":null,"createdBy":"SORENSENS","dateCreated":"2014-04-30","modifiedBy":"ONEDATA","dateModified":"2014-04-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2233878","version":"1","preferredName":"Present","preferredDefinition":"Being or existing in a specified place or at the specified time.","longName":"C25626","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Present","conceptCode":"C25626","definition":"Being or existing in a specified place or at the specified time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F970CDF6-F829-21D3-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-14","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-06-14","modifiedBy":"ONEDATA","dateModified":"2005-06-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2435022","version":"1","preferredName":"Disease, Disorder or Finding","preferredDefinition":"Specification of human conditions relevant to cancer. This includes observations, test results, history, and other concepts relevant to characterization of human cancer-related conditions. Non-neoplastic conditions of interest are also included.","longName":"C7057","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D9-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"CD864119-728C-20DF-E040-BB89AD433C55","latestVersionIndicator":"Yes","beginDate":"2012-11-02","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2012-11-02","modifiedBy":"KUMMEROA","dateModified":"2020-12-16","changeDescription":". 2020-12-16 ak OK to release per WZ","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2940570","version":"1","preferredName":"Accelerated Phase Abnormal Finding Type","preferredDefinition":"(ak-SEL-er-ay-ted) Refers to chronic myelogenous leukemia that is progressing. The number of immature, abnormal white blood cells in the bone marrow and blood is higher than in the chronic phase but not as high as in the blast phase._A decision that an observation or result is outside the parameters considered normal._Type; a subdivision of a particular kind of thing.","longName":"AD_PE_ABN_FND_TYPE","context":"NHLBI","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"100","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Increasing WBC","valueDescription":"Increase Leukocyte Cell Count","ValueMeaning":{"publicId":"2940574","version":"1","preferredName":"Increase Leukocyte Cell Count","longName":"2940574","preferredDefinition":"Increase; a process of becoming larger or more numerous or more important.: White blood cells. These include granular leukocytes (BASOPHILS, EOSINOPHILS, and NEUTROPHILS) as well as non-granular leukocytes (LYMPHOCYTES and MONOCYTES).: A procedure to determine the number of cells in a sample. Also used to mean the result of such a procedure.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Increase","conceptCode":"C25533","definition":"A process of becoming larger, more numerous, more important, or more likely.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Leukocyte","conceptCode":"C12529","definition":"Blood cells that are devoid of hemoglobin, capable of ameboid motion and phagocytosis, and act as the principal components of the immune system.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Cell Count","conceptCode":"C48938","definition":"A procedure to determine the number of cells in a sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"73A66A57-2595-6F4D-E040-BB89AD431B1F","latestVersionIndicator":"Yes","beginDate":"2009-09-15","endDate":null,"createdBy":"MOROZOFA","dateCreated":"2009-09-15","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"73A66A57-25AE-6F4D-E040-BB89AD431B1F","beginDate":"2009-09-15","endDate":null,"createdBy":"MOROZOFA","dateCreated":"2009-09-15","modifiedBy":"ONEDATA","dateModified":"2009-09-15","deletedIndicator":"No"},{"value":"Increasing spleen size","valueDescription":"Increase Spleen Size","ValueMeaning":{"publicId":"2940575","version":"1","preferredName":"Increase Spleen Size","longName":"2940575","preferredDefinition":"Increase; a process of becoming larger or more numerous or more important.: An organ that is part of the lymphatic system. The spleen produces lymphocytes, filters the blood, stores blood cells, and destroys old blood cells. It is located on the left side of the abdomen near the stomach.: Size; the physical magnitude of something.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Increase","conceptCode":"C25533","definition":"A process of becoming larger, more numerous, more important, or more likely.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Spleen","conceptCode":"C12432","definition":"An organ that is part of the hematopoietic and immune systems. It is composed of the white pulp and the red pulp and is surrounded by a capsule. It is located in the left hypochondriac region. Its functions include lymphocyte production, blood cell storage, and blood cell destruction.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Size","conceptCode":"C25681","definition":"The physical magnitude of something.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"73A66A57-25BC-6F4D-E040-BB89AD431B1F","latestVersionIndicator":"Yes","beginDate":"2009-09-15","endDate":null,"createdBy":"MOROZOFA","dateCreated":"2009-09-15","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"73A66A57-25D5-6F4D-E040-BB89AD431B1F","beginDate":"2009-09-15","endDate":null,"createdBy":"MOROZOFA","dateCreated":"2009-09-15","modifiedBy":"ONEDATA","dateModified":"2009-09-15","deletedIndicator":"No"},{"value":"Clonal marrow cytogenetic abnormalities in addition to the single philadelphia chromosome","valueDescription":"Clonality Bone Marrow Cytogenetic Abnormality And Philadelphia Chromosome","ValueMeaning":{"publicId":"2940576","version":"1","preferredName":"Clonality Bone Marrow Cytogenetic Abnormality And Philadelphia Chromosome","longName":"2940576","preferredDefinition":"Related by decent from a single progenitor cell.: The soft, sponge-like tissue in the center of bones that produces white blood cells, red blood cells, and platelets.: An irregularity in the number or structure of chromosomes, usually in the form of a gain (duplication), loss (deletion), exchange (translocation), or alteration in sequence (inversion) of genetic material.: An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence.: An abnormality of chromosome 22 in which part of chromosome 9 is transferred to it.  Bone marrow cells that contain the Philadelphia chromosome are often found in chronic myelogenous leukemia.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Clonality","conceptCode":"C18304","definition":"Related by descent from a single progenitor cell.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"Bone Marrow","conceptCode":"C12431","definition":"The tissue occupying the spaces of bone. It consists of blood vessel sinuses and a network of hematopoietic cells which give rise to the red cells, white cells, and megakaryocytes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Cytogenetic Abnormality","conceptCode":"C2950","definition":"An irregularity in the number or structure of chromosomes, usually in the form of a gain (duplication), loss (deletion), exchange (translocation), or alteration in sequence (inversion) of genetic material.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"And","conceptCode":"C37912","definition":"An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Philadelphia Chromosome","conceptCode":"C28452","definition":"A translocation between chromosomes 9 and 22. It is the hallmark for chronic myelogenous leukemia (CML).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"73A66A57-25E5-6F4D-E040-BB89AD431B1F","latestVersionIndicator":"Yes","beginDate":"2009-09-15","endDate":null,"createdBy":"MOROZOFA","dateCreated":"2009-09-15","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8FD584D3-EF5A-A9D2-E040-BB89AD437E50","beginDate":"2009-09-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2010-09-09","modifiedBy":"ONEDATA","dateModified":"2010-09-09","deletedIndicator":"No"},{"value":"Thrombocytopenia unresponsive to therapy","valueDescription":"Thrombocytopenia Refractory","ValueMeaning":{"publicId":"3135539","version":"1","preferredName":"Thrombocytopenia Refractory","longName":"3135539","preferredDefinition":"A condition in which there is an abnormally small number of platelets in the circulating blood.: Refractory; not responding to treatment.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Thrombocytopenia","conceptCode":"C3408","definition":"A laboratory test result indicating that there is an abnormally small number of platelets in the circulating blood.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Refractory","conceptCode":"C38014","definition":"Not responding to treatment.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8FD584D3-EF67-A9D2-E040-BB89AD437E50","latestVersionIndicator":"Yes","beginDate":"2010-09-09","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2010-09-09","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8FD584D3-EF80-A9D2-E040-BB89AD437E50","beginDate":"2009-09-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2010-09-09","modifiedBy":"ONEDATA","dateModified":"2010-09-09","deletedIndicator":"No"},{"value":"Thrombocytosis unresponsive to therapy","valueDescription":"Thrombocytosis Refractory","ValueMeaning":{"publicId":"3135540","version":"1","preferredName":"Thrombocytosis Refractory","longName":"3135540","preferredDefinition":"Increased numbers of platelets in the peripheral blood. (Dorland, 27th ed): Refractory; not responding to treatment.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Thrombocytosis","conceptCode":"C35530","definition":"A hematology test result that indicates the presence of higher than normal platelet counts in the peripheral blood.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Refractory","conceptCode":"C38014","definition":"Not responding to treatment.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8FD584D3-EF8D-A9D2-E040-BB89AD437E50","latestVersionIndicator":"Yes","beginDate":"2010-09-09","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2010-09-09","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8FD584D3-EFA6-A9D2-E040-BB89AD437E50","beginDate":"2009-09-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2010-09-09","modifiedBy":"ONEDATA","dateModified":"2010-09-09","deletedIndicator":"No"},{"value":"10 to 19 percent blasts in blood or marrow","valueDescription":"Integer::10 To Integer::10 Percentage Blast Count Blood Or Bone Marrow","ValueMeaning":{"publicId":"3192556","version":"1","preferredName":"Integer::10 To Integer::10 Percentage Blast Count Blood Or Bone Marrow","longName":"3192556","preferredDefinition":"A number with no fractional part.::10: Used as a function word to indicate direction, purpose, or movement.: A number with no fractional part.::10: Percentage; a fraction or ratio with 100 understood as the denominator.: The determination of the number of blast cells present in a blood sample.: Blood circulating throughout the body.: Or; used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.: The soft, sponge-like tissue in the center of bones that produces white blood cells, red blood cells, and platelets.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Integer","conceptCode":"C45255","definition":"A number with no fractional part, including the negative and positive numbers as well as zero.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"7"},{"longName":"To","conceptCode":"C65107","definition":"Used as a function word to indicate direction, purpose, or movement.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"6"},{"longName":"Integer","conceptCode":"C45255","definition":"A number with no fractional part, including the negative and positive numbers as well as zero.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"5"},{"longName":"Percentage","conceptCode":"C25613","definition":"A fraction or ratio with 100 understood as the denominator.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"Blast Count","conceptCode":"C74605","definition":"The determination of the number of blast cells present in a biospecimen.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Blood","conceptCode":"C12434","definition":"A liquid tissue; its major function is to transport oxygen throughout the body. It also supplies the tissues with nutrients, removes waste products, and contains various components of the immune system defending the body against infection. Several hormones also travel in the blood.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Or","conceptCode":"C37998","definition":"An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Bone Marrow","conceptCode":"C12431","definition":"The tissue occupying the spaces of bone. It consists of blood vessel sinuses and a network of hematopoietic cells which give rise to the red cells, white cells, and megakaryocytes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9C80BBD3-4E7D-2558-E040-BB89AD435ABF","latestVersionIndicator":"Yes","beginDate":"2011-02-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2011-02-17","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9C80BBD3-4E98-2558-E040-BB89AD435ABF","beginDate":"2010-09-09","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2011-02-17","modifiedBy":"ONEDATA","dateModified":"2011-02-17","deletedIndicator":"No"},{"value":"Greater than or equal to 20 percent basophils in peripheral blood","valueDescription":"Greater Than or Equal To Integer::20 Percentage Blood Basophil","ValueMeaning":{"publicId":"3192557","version":"1","preferredName":"Greater Than or Equal To Integer::20 Percentage Blood Basophil","longName":"3192557","preferredDefinition":"A statement about the relative size or order of two objects specifying that either both objects are the same in quantity or measure or value or status or that the object of interest exceeds the other object in one of these ways.: A number with no fractional part.::20: Percentage; a fraction or ratio with 100 understood as the denominator.: Blood circulating throughout the body.: A type of granular leukocyte with granules that are easily stained by basic stains.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Greater Than or Equal To","conceptCode":"C61583","definition":"A statement about the relative size or order of two objects specifying that either both objects are the same in quantity or measure or value or status or that the object of interest exceeds the other object in one of these ways.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"Integer","conceptCode":"C45255","definition":"A number with no fractional part, including the negative and positive numbers as well as zero.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Percentage","conceptCode":"C25613","definition":"A fraction or ratio with 100 understood as the denominator.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Blood","conceptCode":"C12434","definition":"A liquid tissue; its major function is to transport oxygen throughout the body. It also supplies the tissues with nutrients, removes waste products, and contains various components of the immune system defending the body against infection. Several hormones also travel in the blood.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Basophil","conceptCode":"C12531","definition":"A type of granular leukocyte with granules that are easily stained by basic stains.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9C80BBD3-4EA8-2558-E040-BB89AD435ABF","latestVersionIndicator":"Yes","beginDate":"2011-02-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2011-02-17","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9C80BBD3-4EC3-2558-E040-BB89AD435ABF","beginDate":"2009-09-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2011-02-17","modifiedBy":"ONEDATA","dateModified":"2011-02-17","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2435021","version":"1","preferredName":"Diagnostic or Prognostic Factor","preferredDefinition":"Top level term which includes Biological Markers, Risk Factors, and Prognostic Factors.","longName":"C20047","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741C99A-9B70-231B-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"3163314","version":"1","preferredName":"Accelerated Phase Abnormal Finding Type","preferredDefinition":"(ak-SEL-er-ay-ted) Refers to chronic myelogenous leukemia that is progressing. The number of immature, abnormal white blood cells in the bone marrow and blood is higher than in the chronic phase but not as high as in the blast phase.:A decision that an observation or result is outside the parameters considered normal.:Type; a subdivision of a particular kind of thing.","longName":"C28263:C82547:C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Accelerated Phase","conceptCode":"C28263","definition":"(ak-SEL-er-ay-ted) Refers to chronic myelogenous leukemia that is progressing. The number of immature, abnormal white blood cells in the bone marrow and blood is higher than in the chronic phase but not as high as in the blast phase.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Abnormal Finding","conceptCode":"C82547","definition":"A decision that an observation or result is outside the parameters considered normal.","evsSource":"CTCAE_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"965C810E-0670-4E49-E040-BB89AD4326CC","latestVersionIndicator":"Yes","beginDate":"2010-12-01","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2010-12-01","modifiedBy":"ONEDATA","dateModified":"2010-12-01","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"73A66A57-2526-6F4D-E040-BB89AD431B1F","latestVersionIndicator":"Yes","beginDate":"2009-09-15","endDate":null,"createdBy":"MOROZOFA","dateCreated":"2009-09-15","modifiedBy":"KUMMEROA","dateModified":"2012-03-26","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2695319","version":"1","longName":"NMDP: CDEs to review","context":"NHLBI","ClassificationSchemeItems":[{"publicId":"2964929","version":"1","longName":"2012r1: CML Pre-HSCT Data","context":"NHLBI"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Specify which accelerated pha","type":"Preferred Question Text","description":"Specify which accelerated phase findings were present:","url":null,"context":"NHLBI"},{"name":"Specify which of the following were present:","type":"Alternate Question Text","description":"Specify which of the following were present:","url":null,"context":"NHLBI"}],"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"CD864119-72F7-20DF-E040-BB89AD433C55","latestVersionIndicator":"Yes","beginDate":"2012-11-02","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2012-11-02","modifiedBy":"KUMMEROA","dateModified":"2020-12-16","changeDescription":". 2020-12-16 ak OK to release per WZ.  System generated def displayed as alt def. AK 6/4/15","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}